Search Results

Press Releases

Biora Therapeutics Successfully Completes Restructuring Process

April 1, 2025

·

2 min read

Biotech Beach

Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today shared positive topline results from its clinical trial of BT-600, an orally administered drug-device combination in development for the potential treatment of patients with ulcerative colitis (UC).

July 1, 2024

·

9 min read

Biotech Beach

Biora Therapeutics Provides Outlook for 2024

Biora Therapeutics, Inc., the biotech company that is reimagining therapeutic delivery, provided guidance on anticipated milestones during 2024.

January 16, 2024

·

7 min read

Business

Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update

Biora Therapeutics, Inc., the biotech company that is reimagining therapeutic delivery, announced it will report financial results and provide a corporate update for the first quarter ended March 31, 2024.

May 7, 2024

·

3 min read

Biotech Beach

Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset

Biora Therapeutics, Inc. today announced an agreement with institutional investor Context Capital to invest $2.8 million in new capital.

March 11, 2024

·

5 min read

Business

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.

May 15, 2024

·

11 min read

Biotech Beach

Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600

Biora Therapeutics, Inc today announced completion of dosing for the multiple-ascending dose cohorts for its clinical study of BT-600.

April 30, 2024

·

7 min read

Biotech Beach

Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024

Biora Therapeutics, Inc. presented a poster titled “Results of human device function studies for the NaviCap™ Targeted Oral Delivery Platform in healthy volunteers and patients with UC” at the Digestive Disease Week® conference in Washington DC, on Sunday, May 19, 2024.

May 20, 2024

·

6 min read

Biotech Beach

Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024

Biora Therapeutics, Inc. announced that it will present preclinical data from the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit, which will take place June 18–20, 2024 in Boston.

June 11, 2024

·

5 min read

Business

Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

Biora Therapeutics, Inc today announced it will report financial results and provide a corporate update for the fourth quarter and full year ended December 31, 2023.

March 18, 2024

·

3 min read